Using Cord Blood Stem Cells to Treat
Juvenile Diabetes
Behind Asthma, Type 1 or juvenile diabetes is the second most common chronic childhood disease. It affects 1.5 million Americans today and there are 15,000 new cases diagnosed every year.*
The ViaCord Research Institute ® is committed to supporting important research, like that being conducted for Juvenile Diabetes.
The ViaCord Research Institute® in collaboration with researchers at the University of Massachusetts Medical School, will conduct studies evaluating stem cells using cord blood to treat Type 1 Diabetes. These studies will focus on experiments that analyze the stem cell potential of cord blood and Unrestricted Somatic Stem Cells (USSCs) derived from cord blood.
ViaCord also helped families participate in a clinical trial at the University of Florida using cord blood stem cells to treat Type 1 Diabetes.
The University of Florida cord blood study has received news coverage recently;
*References:
1. Posted June 5, 2008. US News & World Report. Sunlight, Vitamin D May Cut Kids' Diabetes Risk.
2. Study Start Date, April 2005. ClinicalTrials.gov, a service of The NIH. Umbilical Cord Blood Infusion to Treat Type 1 Diabetes.
be an